HIV-1 infection causes, with increasing prevalence, neurological disorders characterized in part by neuronal cell death. The HIV-1 protein Tat has been shown to be directly and indirectly neurotoxic. Here, we tested the hypothesis that a non-neurotoxic epitope of Tat can, through actions on immune cells, increase neuronal cell death. Tat 1-72 and a mutant Tat 1-72 lacking the neurotoxic epitope (Tat Δ31-61 ) concentration-dependently and markedly increased TNF-α production in macrophage-like differentiated human U937 and THP-1 cells, in mouse peritoneal macrophages and in mouse brain microglia. Tat 1-72 was but Tat Δ31-61 was not neurotoxic when applied directly to neurons. Supernatants from U937 cells treated with either Tat 1-72 or Tat Δ31-61 were neurotoxic and their immunoneutralization with an anti-TNF-α antibody decreased Tat 1-72 -and Tat Δ31-61 -induced neurotoxicity. Together, these results demonstrate that the neurotoxic epitope of Tat 1-72 is different from the epitope that is indirectly neurotoxic following production of TNF-α from immune cells, and suggest that therapeutic interventions against TNF-α might be beneficial against HIV-1 associated neurological disorders.
Introduction
HIV-1 associated dementia, a clinical condition marked by ataxia, memory loss, and motor and behavioral abnormalities is increasing in prevalence among HIV-1 infected people and remains an important manifestation of HIV-1 infection (Bouwman et al., 1998; Sacktor et al., 2002; McArthur, 2004; Nath and Berger, 2004; Kaul et al., 2005) . Pathological features of HIV-1 associated dementia include neuron dysfunction and death, demyelination, astrogliosis, and inflammation (Wiley et al., 1998; Rappaport et al., 1999) . The pathogenesis of HIV-1 associated dementia however is complex, ill-understood and multiple mechanisms have been implicated in part because neurons are not infected by HIV-1 (Takahashi et al., 1996) and viral burden does not correlate with disease onset or progression (Glass et al., 1995; Ellis et al., 1997; Wiley et al., 1998) .
Closely linked with the development and progression of HIV-1 associated dementia are early-on infiltration of infected T cells and monocytes, and later recruitment of uninfected macrophages into the CNS. One of the most important clinical and pathological correlates of HIV-associated dementia is the infiltration of activated macrophages into the CNS and the activation of microglia (Brew et al., 1995; Glass et al., 1995; Glass and Wesselingh, 2001 ). Once recruited, peripheral immune cells as well as activated brainresident cells produce a variety of inflammatory mediators, including tumor necrosis factor-α (TNF-α) (Tyor et al., 1992; Glass et al., 1993; Wesselingh et al., 1993; Glass et al., 1995; Wesselingh et al., 1997; Glass and Wesselingh, 2001 ). In addition to the direct effects of HIV-1 virotoxins on neurons, neurotoxic effects can be mediated through the abnormal production, release or relative amounts of cytokines in brain (Nath and Geiger, 1998). TNF-α has been implicated in the pathogenesis of HIV-associated dementia, because elevated levels of TNF-α are present in the serum, CSF and brains of demented AIDS patients (Grimaldi et al., 1991; Glass et al., 1993; Wesselingh et al., 1993) , and the severity of dementia is closely correlated with plasma and brain TNF-α levels (Glass et al., 1993; Wesselingh et al., 1993; Sevigny et al., 2004) . TNF-α may contribute to HIV-1 associated dementia by inducing neuronal dysfunction and death and by synergizing with viral proteins and excitatory amino acids (Shi et al., 1998; Saha and Pahan, 2003) .
Tat is a non-structural HIV-1 protein that is produced and secreted by HIV-infected cells, that controls HIV-1 replication through binding and transactivation of its long terminal repeats (Ensoli et al., 1993) , and that binds to and activates the transcription of host genes such as TNF-α (Buonaguro et al., 1992; Sawaya et al., 1998) . Evidence linking Tat to HIV-1 associated dementia includes findings that Tat increases monocyte/macrophage infiltration into brain, damage to brain-resident cells, and brain levels of TNF-α (Philippon et al., 1994; Jones et al., 1998; Nath and Geiger, 1998; Rappaport et al., 1999; Pu et al., 2003; Saha and Pahan, 2003) . Further linking Tat to the pathogenesis of
